SE392615B - Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat - Google Patents

Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat

Info

Publication number
SE392615B
SE392615B SE7209898A SE989872A SE392615B SE 392615 B SE392615 B SE 392615B SE 7209898 A SE7209898 A SE 7209898A SE 989872 A SE989872 A SE 989872A SE 392615 B SE392615 B SE 392615B
Authority
SE
Sweden
Prior art keywords
imidazolaldehyde
nitro
derivatives
procedure
preparation
Prior art date
Application number
SE7209898A
Other languages
English (en)
Swedish (sv)
Inventor
B Cavalleri
G Lancini
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of SE392615B publication Critical patent/SE392615B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
SE7209898A 1971-07-30 1972-07-28 Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat SE392615B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT4297871 1971-07-30

Publications (1)

Publication Number Publication Date
SE392615B true SE392615B (sv) 1977-04-04

Family

ID=11254772

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7209897A SE417711B (sv) 1971-07-30 1972-07-28 Forfarande for framstellning av 5-iminometyl-2-nitroimidazolderivat
SE7209898A SE392615B (sv) 1971-07-30 1972-07-28 Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE7503080A SE417200B (sv) 1971-07-30 1975-03-18 Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7209897A SE417711B (sv) 1971-07-30 1972-07-28 Forfarande for framstellning av 5-iminometyl-2-nitroimidazolderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7503080A SE417200B (sv) 1971-07-30 1975-03-18 Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat

Country Status (27)

Country Link
US (1) US3954789A (xx)
JP (2) JPS528832B1 (xx)
AR (4) AR199084A1 (xx)
AT (3) AT316545B (xx)
AU (1) AU462723B2 (xx)
BE (1) BE785024A (xx)
CA (1) CA997340A (xx)
CH (4) CH574933A5 (xx)
CS (1) CS180585B2 (xx)
DD (2) DD99996A5 (xx)
DE (2) DE2229248C3 (xx)
DK (1) DK154295C (xx)
ES (3) ES405343A1 (xx)
FI (1) FI57255C (xx)
FR (1) FR2148073B1 (xx)
GB (1) GB1362444A (xx)
HU (2) HU164926B (xx)
IE (1) IE36530B1 (xx)
IL (1) IL39880A (xx)
LU (1) LU65816A1 (xx)
NL (2) NL148602B (xx)
NO (2) NO135592C (xx)
PL (4) PL85190B1 (xx)
RO (6) RO61517A (xx)
SE (3) SE417711B (xx)
SU (4) SU466684A3 (xx)
ZA (1) ZA724723B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1480192A (en) * 1975-01-15 1977-07-20 Lepetit Spa 1-methyl-2-nitro-imidazole-5-methanol derivatives
GB1526451A (en) * 1976-01-27 1978-09-27 Lepetit Spa Alpha,alpha,1-trimethyl-2-nitroimidazole-5-methanol derivatives
US4218460A (en) * 1976-09-29 1980-08-19 Basf Aktiengesellschaft Nitroimidazoles
US4199592A (en) * 1978-08-29 1980-04-22 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-2-nitroimidazoles
ZW24982A1 (en) * 1981-11-30 1983-06-15 Hoffmann La Roche 2-nitroimidazoles
JPH10338673A (ja) * 1997-06-04 1998-12-22 Nippon Bayeragrochem Kk イソニコチン酸ヒドラジド誘導体および有害生物防除剤
ZA200507752B (en) 2003-03-28 2007-01-31 Threshold Pharmaceuticals Inc Compositions and methods for treating cancer
PL1896040T3 (pl) 2005-06-29 2012-12-31 Threshold Pharmaceuticals Inc Proleki alkilatora fosforoamidowego
US8552048B2 (en) 2006-12-26 2013-10-08 Threshold Pharmaceuticals, Inc. Phosphoramidate alkylator prodrugs for the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL124627C (xx) * 1964-08-12
NL143227B (nl) * 1968-11-15 1974-09-16 Lepetit Spa Werkwijze ter bereiding van imidazoolderivaten met bactericide werking.
US3583985A (en) * 1969-04-09 1971-06-08 Richardson Merrell Inc Nitroimidazolyl nitrones
US3711495A (en) * 1970-01-07 1973-01-16 Merck & Co Inc Isoxazalin-3-yl-substituted-5-nitroimidazoles

Also Published As

Publication number Publication date
CH574933A5 (xx) 1976-04-30
RO61517A (xx) 1976-12-15
DE2229248C3 (de) 1980-03-27
DE2229248A1 (de) 1973-02-15
SU463263A3 (ru) 1975-03-05
AR193999A1 (es) 1973-06-12
SE7503080L (xx) 1975-03-18
NL148602B (nl) 1976-02-16
RO63049A (fr) 1978-07-15
RO62787A (xx) 1977-08-15
AR193885A1 (es) 1973-05-31
DE2229223C3 (de) 1975-12-18
AU4422872A (en) 1974-01-10
DK154295B (da) 1988-10-31
SU466684A3 (ru) 1975-04-05
HU164926B (xx) 1974-05-28
CH572040A5 (xx) 1976-01-30
FR2148073B1 (xx) 1975-11-28
DE2229223B2 (de) 1975-05-07
SE417711B (sv) 1981-04-06
CS180585B2 (en) 1978-01-31
NO135592C (xx) 1977-04-27
IL39880A (en) 1976-04-30
PL82980B1 (xx) 1975-12-31
AT316545B (de) 1974-07-10
DE2229223A1 (de) 1973-02-15
BE785024A (fr) 1972-10-16
PL87673B1 (xx) 1976-07-31
NL149491B (nl) 1976-05-17
NL7210340A (xx) 1973-02-01
SU581863A3 (ru) 1977-11-25
FI57255C (fi) 1980-07-10
DD99995A5 (xx) 1973-09-05
PL84350B1 (xx) 1976-03-31
RO63047A (fr) 1978-05-15
AR199084A1 (es) 1974-08-08
DK154295C (da) 1989-03-28
ES418921A1 (es) 1976-10-16
AT323736B (de) 1975-07-25
NO135591C (xx) 1977-04-27
AU462723B2 (en) 1975-07-03
DE2229248B2 (de) 1979-07-26
ZA724723B (en) 1973-04-25
HU167622B (xx) 1975-11-28
AR199680A1 (es) 1974-09-23
GB1362444A (en) 1974-08-07
NO135592B (xx) 1977-01-17
PL85190B1 (xx) 1976-04-30
LU65816A1 (xx) 1972-11-29
ES405341A1 (es) 1975-07-01
US3954789A (en) 1976-05-04
IL39880A0 (en) 1972-09-28
SE417200B (sv) 1981-03-02
IE36530B1 (en) 1976-11-24
RO63048A (fr) 1978-05-15
NO135591B (xx) 1977-01-17
RO63453A (fr) 1978-06-15
CA997340A (en) 1976-09-21
JPS5038111B1 (xx) 1975-12-06
AT315164B (de) 1974-05-10
FI57255B (fi) 1980-03-31
CH574934A5 (xx) 1976-04-30
JPS528832B1 (xx) 1977-03-11
DD99996A5 (xx) 1973-09-05
CH580596A5 (xx) 1976-10-15
ES405343A1 (es) 1975-07-16
IE36530L (en) 1973-01-30
FR2148073A1 (xx) 1973-03-11
NL7210339A (xx) 1973-02-01
SU567404A3 (ru) 1977-07-30

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
SE406197B (sv) Analogiforfarande for framstellning av 4-aminokinazolinderivat
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE417318B (sv) Forfarande for framstellning av oxofurylesterderivat av penicillin
SE399069B (sv) Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE409866B (sv) Forfarande for framstellning av adenosinderivat
SE394680B (sv) Forfarande for framstellning av cykliska fosfamidderivat
SE384210B (sv) Forfarande for framstellning av nya nitrosokarbamidderivat
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE7510790L (sv) Forfarande for framstellning av 2- eller 3-cefemderivat
SE407061B (sv) Forfarande for framstellning av bensylpyrimidiner
SE387948B (sv) Forfarande for framstellning av tiofen